dSLIMming the immune system

The immune system normally doesn't recognize antigens associated with cancer as "other," which has made developing cancer vaccines difficult. Mologen AG thinks its dSLIM adjuvant may act as an immune modulator that sensitizes the immune system to antigens that it would normally overlook.

"dSLIM is

Read the full 454 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE